loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 24d75b58 Bafb 4440 B8d7 4f4079c08b0b Applno 20863 Form Tablet Oral Dosage 50mg - Drug Product Composition: Cilostazol

    Menu

    Cilostazol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 252Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 20863 / DOSAGE - TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    cilostazol(UNII: N7Z035406B)
    (cilostazol - UNII:N7Z035406B)     		cilostazol100mg | 50mg

    Inactive Ingredients

    Ingredient Name
    Otsuka America Pharmaceutical, Inc.
    carboxymethylcellulose calcium(UTY7PDF93L)
    carboxymethylcellulose(05JZI7B19X)
    magnesium stearate(70097M6I30)
    MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
    starch, corn(O8232NY3SJ)